Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Efficacy and safety of polatuzumab vedotin–based regimens in newly diagnosed diffuse large B-cell lymphoma: A single-center retrospective study

Taiyuan Zhang, Yingying Wu, Zhipeng Cheng, Ao Zhang, Lin Liu, Lu Zhang, Danying Liao, Wei Xie, Fang Liu, Guohui Cui, Yu Hu, Heng Mei, Jun Fang

Blood (2025) 146 (Supplement 1): 7207.

https://doi.org/10.1182/blood-2025-7207

Published: 2025

Journal Articles

Spatial asymmetry of blasts in bone marrow after hematopoietic stem cell transplantation for AML/MDS

Ruowen Wei, Ao Zhang, Moran Wang, Ruiqi Zhu, Donald Small, Xie-Na Cao, Yanmin Zhao, Linghui Xia, Wei Shi

Blood (2025) 146 (Supplement 1): 6040.

https://doi.org/10.1182/blood-2025-6040

Published: 2025

Journal Articles

Efficacy and Safety of Single-Dose Versus Split-Dose Mecapegfilgrastim with Etoposide for Autologous Peripheral Blood Stem Cell Mobilization: A Prospective, Randomized Clinical Trial

Blood (2024) 144 (Supplement 1): 4855.

https://doi.org/10.1182/blood-2024-202870

Published: 2024

Journal Articles

CD33 Antibody-Modified Nanoparticles Encapsulated IL-15 Induce ISG15 to Promote MHC I Expression in Leukemia Cells Via Innate Immunity Pathway Inducing Graft-Versus-Leukemia without Aggravating Graft-Versus-Host Disease

Ruowen Wei, Ao Zhang, Moran Wang, Xie-Na Cao, Ruiqi Zhu, Shengling Ma, Linghui Xia, Wei Shi

Blood (2024) 144 (Supplement 1): 904.

https://doi.org/10.1182/blood-2024-200551

Published: 2024

Journal Articles

A Prospective Clinical Study of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Double Expression Diffuse Large B-Cell Lymphoma

Yingying Wu, Ao Zhang, Liling Zhang, Guohui Cui, Fang Liu, Zhichao Chen, Zhipeng Chen, Lu Zhang, Lin Liu, Wenjuan He, Yu Hu, Linghui Xia, Jun Fang

Blood (2024) 144 (Supplement 1): 6501.

https://doi.org/10.1182/blood-2024-202483

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Efficacy and safety of polatuzumab vedotin–based regimens in newly diagnosed diffuse large B-cell lymphoma: A single-center retrospective study

Spatial asymmetry of blasts in bone marrow after hematopoietic stem cell transplantation for AML/MDS

Efficacy and Safety of Single-Dose Versus Split-Dose Mecapegfilgrastim with Etoposide for Autologous Peripheral Blood Stem Cell Mobilization: A Prospective, Randomized Clinical Trial

CD33 Antibody-Modified Nanoparticles Encapsulated IL-15 Induce ISG15 to Promote MHC I Expression in Leukemia Cells Via Innate Immunity Pathway Inducing Graft-Versus-Leukemia without Aggravating Graft-Versus-Host Disease

A Prospective Clinical Study of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Double Expression Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Efficacy and safety of polatuzumab vedotin–based regimens in newly diagnosed diffuse large B-cell lymphoma: A single-center retrospective study

Spatial asymmetry of blasts in bone marrow after hematopoietic stem cell transplantation for AML/MDS

Efficacy and Safety of Single-Dose Versus Split-Dose Mecapegfilgrastim with Etoposide for Autologous Peripheral Blood Stem Cell Mobilization: A Prospective, Randomized Clinical Trial

CD33 Antibody-Modified Nanoparticles Encapsulated IL-15 Induce ISG15 to Promote MHC I Expression in Leukemia Cells Via Innate Immunity Pathway Inducing Graft-Versus-Leukemia without Aggravating Graft-Versus-Host Disease

A Prospective Clinical Study of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Double Expression Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only